Picture of PeptiDream logo

4587 — PeptiDream News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Table: Peptidream -6-MTH group results (IFRS)

Aug 9 (Reuters)- 
              Peptidream Inc. 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2022        Jun 30, 2021     Dec 31, 2022 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales               5.02                2.92             24.50    
                   (+72.2 pct)                         (+160.0 pct) 
  Operating         loss 1.56            436 mln                    
  Pretax            loss 1.48            312 mln                    
  Net               loss 1.06          loss 8 mln                   
  EPS Basic       loss 8.13 yen       loss 0.07 yen                 
  EPS Diluted     loss 8.13 yen       loss 0.07 yen                 
  Ann Div                                  NIL              NIL     
  -Q2 Div              NIL                 NIL                      
  -Q4 Div                                  NIL              NIL     
 
  NOTE - Peptidream Inc.. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T

Recent news on PeptiDream

See all news